ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Do Powerful Induction Antibodies Increase Post Renal Transplant Infections?

    M. John, I. Dortonne, B. Kim, C. Li, M. Killackey, A. Paramesh, B. Lee, R. Zhang, G. Parker, J. Buell.

    Transplant Institute, Tulane University School of Medicine, New Orleans, LA.

    Purpose: Infection is one of the most common and costly complications of solid organ transplantation. Alemtuzemab (AL) is a powerful antibody that significantly reduced rejection…
  • 2016 American Transplant Congress

    Hepatitis B Immune Globulin Withdrawal in HBsAg Positive Liver Transplant Patients.

    A. Nolan,1 C. Onwudiwe,1 A. Rangnekar,2 R. Satoskar,2 T. Fishbein.2

    1Department of Pharmacy, Medstar Georgetown University Hospital, Washington, DC; 2Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.

    Introduction: Liver transplantation for chronic hepatitis B virus (HBV) is associated with a high recurrence rate of HBV post-transplant without the use of prophylaxis. The…
  • 2016 American Transplant Congress

    Ischemia-Reperfusion Injury Following Transplantation: Implications for the Modulation of CXCL8 Chemokine Function.

    B. Martinez Burgo,1 S. Ali,1 J. Kirby,1 N. Sheerin,1 S. Cobb,2 D. Kashanin.3

    1Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, United Kingdom; 2Chemistry Department, Durham University, Durham, United Kingdom; 3Cellix Ltd., Dublin, Ireland.

    Ischemia-Reperfusion Injury (IRI) is a major contributor to subsequent graft dysfunction. Chemokines play a key role in leukocyte recruitment towards to the injured tissue. CXCL8…
  • 2016 American Transplant Congress

    Elevated Urinary 11-Dehydrothromboxane B2 Is Associated with Increased Bleeding Risk in Left Ventricular Assist Device Patients.

    W. Schultz,4 A. Pekarek,3 R. Cole,1 A. Duncan,5 S. Laskar,1 A. Smith,1 D. Nguyen,2 J. Vega, D. Gupta.1

    1Division of Cardiology, Emory University School of Medicine, Atlanta, GA; 2Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, GA; 3Heart Transplant Services, Emory University Hospital, Atlanta, GA; 4Department of Medicine, Emory University School of Medicine, Atlanta, GA; 5Department of Pathology, Emory University School of Medicine, Atlanta, GA.

    Purpose: To understand if there is a relationship between aspirin resistance as measured by elevated levels of urinary 11-dehydrothromboxane B2 in patients supported with continuous…
  • 2016 American Transplant Congress

    Normothermic Ex-Vivo Perfusion of the Intestine: The Introduction of an Innovative Physiologic Model with Novel Biomarkers.

    B. Soliman, T. Okamoto, C. Quintini, Q. Liu, M. Fujiki, A. Khanna, K. Hashimoto, J. Fung, K. Abu-Elmagd.

    General Surgery, Transplant Center, Cleveland Clinic Foundation, Cleveland, OH.

    Purpose: Ischemia reperfusion injury is a major risk factor for short and long-term functional survival after intestinal transplantation. Normothermic machine perfusion is an emerging biotechnology…
  • 2016 American Transplant Congress

    Effects of Immunosuppression and Sun Exposure on Immune Cell Populations in Skin and Blood of Kidney Transplant Recipients.

    M. Burke,1 L. Nahum,4 N. Isbel,1 R. Carroll,3 H. Soyer,1 R. Francis,1 J. Bridge,1 C. Staatz,2 J. Wells.1

    1Translational Research Institute, Brisbane, Australia; 2University of Queensland, Brisbane, Australia; 3Royal Adelaide Hospital, Adelaide, Australia; 4Ben Gurion University of the Negev, Beersheba, Israel.

    BackgroundKidney transplant recipients (KTR) receiving sirolimus accrue fewer skin cancers than KTR receiving calcineurin inhibitor (CNI) based immunosuppression, potentially due to effects of sirolimus and…
  • 2016 American Transplant Congress

    The Finances of Broader Sharing of Livers Following Share 35.

    A. Harper,1 E. Edwards,1 R. Gilroy,2 W. Chapman,3 D. Mulligan,4 G. Klintmalm.5

    1Research, UNOS, Richmond, VA; 2Univ.of Kansas Med Ctr, Kansas City, KS; 3Washington Univ, St Louis, MO; 4Yale Med Ctr, New Haven, CT; 5Baylor Univ, Houston, TX.

    Background. After implementation of the “Share 35” policy in 2013, many centers and OPOs reported increased costs associated with broader sharing. The OPTN Liver and…
  • 2016 American Transplant Congress

    Influence of the Tacrolimus Metabolism Rate on BKV Infection After Kidney Transplantation.

    G. Thölking,1 C. Schmidt,1 K. Schuette-Nuetgen,1 D. Pabst,1 R. Koch,2 H. Wolters,3 S. Reuter,1 B. Suwelack.1

    1Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of Münster, Münster, Germany; 2Institute of Biometrics and Clinical Research, University of Münster, Münster, Germany; 3Department of General Surgery, University Hospital of Münster, Münster, Germany.

    Introduction: BK virus (BKV) infection is a serious complication following renal transplantation (RTx). The minimization of risk factors that predict BKV infection might help to…
  • 2016 American Transplant Congress

    Implementation of Telehealth Is Associated with Improved Timeliness of Kidney Transplant Waitlist Evaluation at a VA Center.

    R. Forbes,1,2 K. Kummerow Broman,1,2 T. Johnson,2 D. Rybacki,2 M. Hagemann,2 A. Hannah-Gillis,2 I. Feurer,1 D. Hale.1,2

    1TN Valley HS, Nashville, TN; 2Vanderbilt University Medical Center, Nashville, TN.

    Background: The VA National Transplant Program is challenged to provide timely kidney transplant evaluation for Veterans nationwide. Efforts to improve access have included implementing a…
  • 2016 American Transplant Congress

    Predictive Model for Medication Errors in a Chronic Kidney Transplant Clinic.

    K. Covert,1 C. Mardis,1 J. Fleming,1 A. Mardis,1 H. Meadows,1 N. Pilch,1 P. Mohan,2 M. Posadas,2 M. Salazar,2 T. Srinivas,2 G. Mour,2 D. Taber.1

    1Pharmacy, The Medical University of South Carolina, Charleston, SC; 2Transplant Nephrology, The Medical University of South Carolina, Charleston, SC.

    Medication errors are associated with increased incidence of infection, rejection, and graft loss in kidney transplant recipients. This study aims to create a model to…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences